One of the largest tobacco companies in the world has launched a cannabis investment of $ 1.8 billion in Cronos Group, Canadian medical and recreational marijuana.
Altria, which manufactures Marlboro cigarettes, earns a 45% stake in Cronos, the company said on Friday. Toronto.
He added that the tobacco company Richmond, Virginia, will pay to others 1,400 million dollars for guarantees that would, if executed, have provided Altria with a majority stake in 55% of the property.
This would mean that Altria's investment will be at the same level as $ 4 billion last year by Constellation Brands to acquire Altria's shares. Canopy Growth Corp., another Canadian marijuana maker.
The investment, made in August by Constellation, which manufactures Corona and other beverages, was the largest ever largest US company on the cannabis market.
Notwithstanding the hesitation of large corporations United States of America As regards entry to the cannabis market, it appears to disappear if there is a financial justification.
Altria's huge investments have encouraged cannabis companies that have begun to settle in the area Canada, where their recreational consumption was legalized this year.
Shares of Cronos Group Inc. increased by 31% and approached the historic peak on Friday.
It is expected that the rapid growth of the cannabis market will continue as legalization in the United States is expanding and social standards will change. On Tuesday, the ultra-conservative state of Utah became the last state to legalize the use of marijuana for medical purposes.
Consumers are expected to spend $ 57,000 million a year in legal hemp for 2027, says Arcview Market Research, a hemp investment firm.
Expenditure is expected in North America $ 9,200 million in 2017 to $ 47,300 million in 2027.